AIMC Topic: Urinary Bladder Neoplasms

Clear Filters Showing 11 to 20 of 397 articles

Will artificial intelligence (AI) replace cytopathologists: a scoping review of current applications and evidence of A.I. in urine cytology.

World journal of urology
PURPOSE: Urine cytology, while valuable in facilitating the detection and surveillance of bladder cancer, has notable limitations. The application of artificial intelligence (AI) in urine cytology holds significant promise for improving diagnostic ac...

Deep learning on T2WI to predict the muscle-invasive bladder cancer: a multi-center clinical study.

Scientific reports
To develop a deep learning (DL) model based on MRI to predict muscle-invasive bladder cancer (MIBC). A total of 559 patients, including 521 patients in our center and 38 patients in external centers were collected from 2012 to 2023 to construct the D...

Machine Learning and Mendelian Randomization Reveal a Tumor Immune Cell Profile for Predicting Bladder Cancer Risk and Immunotherapy Outcomes.

The American journal of pathology
This study's objective was to develop predictive models for bladder cancer (BLCA) using tumor infiltrated immune cell (TIIC)-related genes. Multiple RNA expression data and scRNA-seq were downloaded from the TCGA and GEO databases. A tissue specifici...

Using machine learning for predicting cancer-specific mortality in bladder cancer patients undergoing radical cystectomy: a SEER-based study.

BMC cancer
BACKGROUND: Accurately assessing the prognosis of bladder cancer patients after radical cystectomy has important clinical and research implications. Current models, based on traditional statistical approaches and complex variables, have limited perfo...

Enhanced Artificial Intelligence in Bladder Cancer Management: A Comparative Analysis and Optimization Study of Multiple Large Language Models.

Journal of endourology
With the rapid advancement of artificial intelligence in health care, large language models (LLMs) demonstrate increasing potential in medical applications. However, their performance in specialized oncology remains limited. This study evaluates the...

Development of an artificial intelligence-generated, explainable treatment recommendation system for urothelial carcinoma and renal cell carcinoma to support multidisciplinary cancer conferences.

European journal of cancer (Oxford, England : 1990)
BACKGROUND: Decisions on the best available treatment in clinical oncology are based on expert opinions in multidisciplinary cancer conferences (MCC). Artificial intelligence (AI) could increase evidence-based treatment by generating additional treat...

A CT-based interpretable deep learning signature for predicting PD-L1 expression in bladder cancer: a two-center study.

Cancer imaging : the official publication of the International Cancer Imaging Society
BACKGROUND: To construct and assess a deep learning (DL) signature that employs computed tomography imaging to predict the expression status of programmed cell death ligand 1 in patients with bladder cancer (BCa).

Leveraging Deep Learning in Real-Time Intelligent Bladder Tumor Detection During Cystoscopy: A Diagnostic Study.

Annals of surgical oncology
BACKGROUND: Accurate detection of bladder lesions during cystoscopy is crucial for early tumor diagnosis and recurrence monitoring. However, conventional visual inspection methods have low and inconsistent detection rates. This study aimed to evaluat...

Predicting 90-day risk of urinary tract infections following urostomy in bladder cancer patients using machine learning and explainability.

Scientific reports
This research aims to design and validate a machine learning model to predict the probability of urinary tract infections within 90 days post-urostomy in bladder cancer patients. Clinical and follow-up information from 317 patients who had urostomy p...

Pathology-based deep learning features for predicting basal and luminal subtypes in bladder cancer.

BMC cancer
BACKGROUND: Bladder cancer (BLCA) exists a profound molecular diversity, with basal and luminal subtypes having different prognostic and therapeutic outcomes. Traditional methods for molecular subtyping are often time-consuming and resource-intensive...